Decrease in blood miR-296 predicts chemotherapy resistance and poor clinical outcome in patients receiving systemic chemotherapy for metastatic colon cancer

International Journal of Colorectal Disease

Volumn 28, Issue 6, 2013, Pages 887-

  Shivapurkar, N ^a   Mikhail, S ^a   Navarro, R ^a   Bai, W ^a   Marshall, J ^a   Hwang, J ^a   Pishvaian, M ^a   Wellstein, A ^a   He, A R ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; MICRORNA; MICRORNA 296; SUNITINIB; UNCLASSIFIED DRUG;

BLOOD LEVEL; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; COLON CANCER; COLON METASTASIS; CORRELATION ANALYSIS; HUMAN; LETTER; PHASE 2 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL; THERAPY RESISTANCE; TREATMENT OUTCOME;

COLONIC NEOPLASMS; DEOXYCYTIDINE; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; HUMANS; INDOLES; MICRORNAS; NEOPLASM METASTASIS; PYRROLES; TREATMENT OUTCOME;

EID: 84878538774     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1560-1     Document Type: Letter

References (0)